The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.
Saved in:
| Title: | The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus. |
|---|---|
| Authors: | Goldberg JF; Department of Psychiatry, https://ror.org/04a9tmd77Icahn School of Medicine at Mount Sinai, New York, New York, USA., Swartz HA; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., McIntyre RS; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Mago R; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, USA.; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Malhi GS; Academic Department of Psychiatry, Kolling Institute, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; CADE Clinic and Mood-T, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.; Department of Psychiatry, University of Oxford, Oxford Uehiro Centre for Practical Ethics, Faculty of Philosophy, University of Oxford, Oxford, UK., Jha MK; Center for Depression Research and Clinical Care, Peter O'Donnell Jr. Brain Institute and the Department of Psychiatry, UT Southwestern Medical Center, Dallas, Texas, USA., Berk M; Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Barwon Health, Geelong, Victoria, Australia.; Mental Health, Drugs and Alcohol Service, Barwon Health, Geelong, Victoria, Australia., Kasper S; Department of Psychiatry and Psychotherapy, Clinical Division of General Psychiatry, Medical University of Vienna, Vienna, Austria.; Center for Brain Research, Department of Molecular Neuroscience, Medical University of Vienna, Vienna, Austria., Freeman MP; Department of Psychiatry, Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA., Gitlin MJ; Department of Psychiatry, Geffen School of Medicine at UCLA, Los Angeles, California, USA., Sajatovic M; Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA., Ostacher MJ; United States Department of Veterans Affairs, Palo Alto, Health Care System, Palo Alto, California, USA.; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA., Citrome L; Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, New York, USA., Iosifescu DV; Nathan Kline Institute, Orangeburg, New York, USA.; New York University Grossman School of Medicine, New York, New York, USA., Perlis RH; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.; Center for Quantitative Health, Massachusetts General Hospital, Boston, Massachusetts, USA., Furukawa TA; Office of Institutional Advancement and Communications, Kyoto University, Japan.; Graduate School of Medicine / School of Public Health, Kyoto University, Japan., Vieta E; Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Institute of Neurosciences (UBNeuro), University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biomedical Research Networking Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Medicine, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Thase ME; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Corporal Michael J Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA., Young AH; Centre for Affective Disorders (CfAD), Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK., Tohen M; Department of Psychiatry & Behavioral Sciences, University of New Mexico, Albuquerque, New Mexico, USA., Nierenberg AA; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.; Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Harvard Medical School, Boston, New Mexico, USA., Macaluso M; Department of Psychiatry and Behavioral Neurobiology, The University of Alabama Heersink School of Medicine, Birmingham, Alabama, USA., Shelton RC; Department of Psychiatry and Behavioral Neurobiology, The University of Alabama Heersink School of Medicine, Birmingham, Alabama, USA., Correll CU; The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, USA.; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany., Aaronson ST; Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland, USA., Rosenblat JD; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada., Gorwood P; INSERM U1266, Institute of Psychiatry and Neurosciences of Paris (IPNP), Université Paris Cité, Paris, France.; GHU Paris Psychiatrie et Neurosciences (CMME), Sainte-Anne Hospital, Paris, France., Khan A; Northwest Clinical Research Center, Bellevue, Washington, USA., Kupka R; Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, Netherlands., Cohen LJ; Department of Pharmacotherapy, College of Pharmacy and Health Professions, University of North Texas Health, Fort Worth, Texas, USA.; Department of Pharmacy Practice, College of Pharmacy, Touro University, New York City, New York, USA., Mitchell PB; Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, New South Wales, Australia., Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA., Sanacora G; Department of Psychiatry, Yale University, Yale-New Haven Hospital, New Haven, Connecticut, USA., Kane JM; The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, USA.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, New York, USA., Rubio-Lorente JM; The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, USA.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, New York, USA., Goodman DW; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, USA.; Department of Psychiatry, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA., Zohar J; Psychiatric Division, Chaim Sheba Medical Center, Tel Hashomer, Israel., Davis L; Department of Psychiatry and Behavioral Neurobiology, The University of Alabama Heersink School of Medicine, Birmingham, Alabama, USA., Gupta S; Department of Psychiatry, https://ror.org/04a9tmd77Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Castle Point VA Medical Center, Wappingers Falls, New York, USA., Steingard S; Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, Vermont, USA., Zarate CA; Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA., Clayton AH; Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA. |
| Source: | The British journal of psychiatry : the journal of mental science [Br J Psychiatry] 2026 Mar 25, pp. 1-9. Date of Electronic Publication: 2026 Mar 25. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Cambridge University Press Country of Publication: England NLM ID: 0342367 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-1465 (Electronic) Linking ISSN: 00071250 NLM ISO Abbreviation: Br J Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
